IP Library Granted Patent US 7,862,696
Granted Patent B2
US 7,862,696 · App. 11/853,010 · Granted Jan 4, 2011

Biosensor system having enhanced stability and hematocrit performance

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,862,696
App. No.
11/853,010
Granted
Jan 4, 2011
Kind
B2
Abstract

The present invention relates to electrochemical sensor strips and methods of determining the concentration of an analyte in a sample or improving the performance of a concentration determination. The electrochemical sensor strips may include at most 8 μg/mm 2 of a mediator. The strips, the strip reagent layer, or the methods may provide for the determination of a concentration value having at least one of a stability bias of less than ±10% after storage at 50° C. for 4 weeks when compared to a comparison strip stored at −20° C. for 4 weeks, a hematocrit bias of less than ±10% for whole blood samples including from 20 to 60% hematocrit, and an intercept to slope ratio of at most 20 mg/dL. A method of increasing the performance of a quantitative analyte determination also is provided.

Claims (30)

1. An electrochemical sensor strip for detecting an analyte, comprising:

a base;

a first electrode on the base having at least one first layer on a first conductor, the first layer including a reagent layer comprising

at most 8 μg/mm 2 of a mediator, and

an enzyme system at a deposition density of at most 0.8 μg/mm 2 ;

a second electrode on the base;

a lid on the base; and

where the strip provides a determined concentration value having at least one of a stability bias of less than ±10% after storage at 50° C. for 2 weeks when compared to a comparison strip stored at −20° C. for 2 weeks, a hematocrit bias of less than ±10% for whole blood samples including from 20 to 60% hematocrit, and an intercept to slope ratio of at most 20 mg/dL.

2. The strip of claim 1 , where the second electrode also comprises the at least one first layer on a second conductor.

3. The strip of claim 1 , where the average initial thickness of the reagent layer is less than 8 μm.

4. The strip of claim 1 , where the reagent layer is formed at a deposition density of at most 0.2 μL/mm 2 from a reagent solution.

5. The strip of claim 1 , where the reagent layer comprises a partially water soluble polymeric binder that forms a gel-like material on hydration.

6. The strip of claim 1 , where the reagent layer comprises at most 1.3 Units of an enzyme system.

7. The strip of claim 1 , where the reagent layer comprises at most 2 μg/mm 2 of the mediator.

8. The strip of claim 1 , where the stability bias is less than ±5% after storage at 50° C. for 2 weeks when compared to the comparison strip stored at −20° C. for 2 weeks.

9. The strip of claim 1 , where the stability bias is less than ±5% after storage at 50° C. for 4 weeks when compared to the comparison strip stored at −20° C. for 4 weeks.

10. The strip of claim 1 , where the hematocrit bias is less than ±5% for the whole blood samples including from 20 to 60% hematocrit.

11. The strip of claim 1 , where the intercept to slope ratio is at most 10 mg/dL.

12. The strip of claim 1 , where the intercept to slope ratio is at most 1 mg/dL.

13. The strip of claim 1 , where the first and second electrodes are in substantially the same plane.

14. The strip of claim 1 , where the electrodes are separated by greater than 200 μm.

15. The strip of claim 1 , where the electrodes are separated from an upper portion of the lid by at least 100 μm.

16. The strip of claim 1 , where the average initial thickness of the reagent layer is from 0.25 to 3 μm.

17. The strip of claim 1 , where the reagent layer comprises a polymeric binder selected from the group consisting of poly(ethylene oxide), polyvinyl alcohol, hydroxyethylene cellulose, carboxy methyl cellulose, and combinations thereof.

18. The strip of claim 17 , where the deposition density of the polymeric binder is at most 2 μg/mm 2 on the first conductor.

19. The strip of claim 1 , where the second electrode further comprises a second layer on the second conductor.

20. The strip of claim 19 , where the second layer comprises a reagent layer different in composition from the reagent layer of the first layer.

21. The strip of claim 1 , where the mediator is a two electron transfer mediator.

22. The strip of claim 21 , where the mediator has a redox potential at least 100 mV lower than ferricyanide.

23. The strip of claim 21 , where the mediator is selected from the group consisting of 3 phenylimino-3H-phenothiazines, 3 phenylimino-3H phenoxazines, salts thereof, acids thereof, derivatives thereof, and combinations thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2016
From: BAYER HEALTHCARE LLC
To: ASCENSIA DIABETES CARE HOLDINGS AG
Reel/Frame 037880/0604 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2007
From: WU, HUAN-PING; NELSON, CHRISTINE D.; SPRADLIN, HOPE G.; MAURER, ERIC
To: BAYER HEALTHCARE LLC
Reel/Frame 019964/0457 →